Biotechnology
The Biotechnology industry has a total of 585 stocks, with a combined market cap of $1.29 trillion and total revenue of $116.08 billion.
Market Cap
1.29T
Revenue
116.08B
Profits
-38.07B
PE Ratio
n/a
Profit Margin
-32.80%
Dividend Yield
0.04%
585 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 130.09B | -0.27% | 638,513 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.35B | 0.06% | 382,920 | 15.53B |
| 3 | ARGX | argenx SE | 61.24B | 0.50% | 200,535 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 58.14B | 1.29% | 8,832,060 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 41.99B | -4.36% | 3,036,674 | - |
| 6 | ONC | BeOne Medicines AG | 39.58B | 0.46% | 356,693 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 33.62B | - | 2,157,597 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.03B | 0.46% | 853,904 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 28.58B | 0.18% | 6,181,184 | 7.53M |
| 10 | INSM | Insmed Incorporated | 26.77B | 2.22% | 1,433,808 | 1.14B |
| 11 | INCY | Incyte Corporation | 25.29B | 2.47% | 1,346,401 | 5.82B |
| 12 | BNTX | BioNTech SE | 24.07B | -0.89% | 407,400 | 3.03B |
| 13 | GMAB | Genmab A/S | 20.39B | 0.73% | 2,885,965 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 16.27B | 3.30% | 1,259,985 | 1.20B |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15.81B | 1.15% | 602,192 | 4.60B |
| 16 | EXEL | Exelixis, Inc. | 14.07B | -0.21% | 1,879,628 | 2.44B |
| 17 | SMMT | Summit Therapeutics Inc. | 13.80B | -0.57% | 6,087,741 | - |
| 18 | BBIO | BridgeBio Pharma, Inc. | 13.35B | -0.13% | 4,928,436 | 713.07M |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 12.53B | 0.43% | 2,252,492 | 3.41B |
| 20 | HALO | Halozyme Therapeutics, Inc. | 12.31B | 2.06% | 1,709,841 | 1.66B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.22B | 1.11% | 298,471 | 1.28B |
| 22 | CORT | Corcept Therapeutics Incorporated | 12.09B | 0.89% | 668,636 | 830.81M |
| 23 | TECH | Bio-Techne Corporation | 11.34B | -0.01% | 3,650,047 | 1.22B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 11.10B | 3.87% | 644,937 | 776.57M |
| 25 | KRYS | Krystal Biotech, Inc. | 9.97B | - | 251,839 | 440.48M |
| 26 | KYMR | Kymera Therapeutics, Inc. | 9.67B | 2.81% | 653,753 | 105.00M |
| 27 | CYTK | Cytokinetics, Incorporated | 9.65B | 0.12% | 2,211,685 | 67.67M |
| 28 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.29B | -6.91% | 5,112,388 | 669.50M |
| 29 | PTGX | Protagonist Therapeutics, Inc. | 9.24B | -0.39% | 507,311 | 281.99M |
| 30 | ABVX | ABIVAX Société Anonyme | 9.10B | -4.15% | 1,894,195 | 5.67M |
| 31 | TWST | Twist Bioscience Corporation | 8.97B | 3.60% | 2,409,436 | 431.80M |
| 32 | PCVX | Vaxcyte, Inc. | 8.75B | -0.74% | 1,249,168 | - |
| 33 | PRAX | Praxis Precision Medicines, Inc. | 8.63B | -1.25% | 545,766 | 7.46M |
| 34 | IBRX | ImmunityBio, Inc. | 8.38B | -2.83% | 9,204,975 | 165.79M |
| 35 | SYRE | Spyre Therapeutics, Inc. | 8.04B | 0.24% | 1,257,627 | - |
| 36 | CAI | Caris Life Sciences, Inc. | 7.97B | -1.02% | 4,302,471 | 989.61M |
| 37 | TGTX | TG Therapeutics, Inc. | 7.92B | 5.30% | 2,350,124 | 799.54M |
| 38 | IMVT | Immunovant, Inc. | 7.51B | -0.74% | 1,169,239 | - |
| 39 | IONS | Ionis Pharmaceuticals, Inc. | 7.45B | -5.10% | 7,958,200 | 874.09M |
| 40 | BLTE | Belite Bio, Inc | 6.81B | -0.14% | 107,337 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.75B | 1.28% | 921,414 | 239.92M |
| 42 | CGON | CG Oncology, Inc. | 6.57B | 2.16% | 795,645 | 6.23M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 6.32B | 3.70% | 991,185 | 618.07M |
| 44 | ORKA | Oruka Therapeutics, Inc. | 6.19B | 1.46% | 926,976 | - |
| 45 | SRRK | Scholar Rock Holding Corporation | 6.01B | -1.26% | 3,657,627 | - |
| 46 | TVTX | Travere Therapeutics, Inc. | 5.98B | 1.55% | 2,221,272 | 591.33M |
| 47 | DNTH | Dianthus Therapeutics, Inc. | 5.73B | -2.18% | 1,035,536 | 1.90M |
| 48 | COGT | Cogent Biosciences, Inc. | 5.65B | -0.61% | 1,921,340 | - |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.64B | 2.96% | 1,397,895 | 1.01B |
| 50 | XENE | Xenon Pharmaceuticals Inc. | 5.50B | 0.85% | 723,626 | 7.50M |
| 51 | LGND | Ligand Pharmaceuticals Incorporated | 5.49B | -0.64% | 299,041 | 290.54M |
| 52 | ERAS | Erasca, Inc. | 5.37B | -5.48% | 6,086,089 | - |
| 53 | DFTX | Definium Therapeutics, Inc. | 5.09B | 2.80% | 2,069,797 | - |
| 54 | CRSP | CRISPR Therapeutics AG | 5.05B | 0.73% | 2,667,363 | 13.39M |
| 55 | EWTX | Edgewise Therapeutics, Inc. | 4.93B | 4.15% | 1,684,314 | - |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 4.75B | 2.91% | 1,405,147 | 1.14B |
| 57 | PBLS | Parabilis Medicines, Inc. | 4.56B | 3.25% | 971,054 | 148.00K |
| 58 | IOVA | Iovance Biotherapeutics, Inc. | 4.47B | 5.45% | 19,693,852 | 324.97M |
| 59 | MANE | Veradermics, Incorporated | 4.28B | -1.41% | 860,353 | - |
| 60 | RLAY | Relay Therapeutics, Inc. | 4.13B | -0.69% | 2,116,667 | 10.35M |
| 61 | TLX | Telix Pharmaceuticals Limited | 4.09B | -7.79% | 642,129 | 890.79M |
| 62 | CELC | Celcuity Inc. | 4.04B | -0.15% | 799,268 | - |
| 63 | TNGX | Tango Therapeutics, Inc. | 3.94B | -2.26% | 2,835,542 | 53.81M |
| 64 | ABCL | AbCellera Biologics Inc. | 3.78B | 2.28% | 4,543,847 | 66.17M |
| 65 | IDYA | IDEAYA Biosciences, Inc. | 3.64B | 0.19% | 639,913 | 234.13M |
| 66 | ELVN | Enliven Therapeutics, Inc. | 3.60B | -7.95% | 2,914,695 | - |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.44B | -1.44% | 3,009,486 | - |
| 68 | TARS | Tarsus Pharmaceuticals, Inc. | 3.41B | -0.75% | 658,796 | 606.33M |
| 69 | LEGN | Legend Biotech Corporation | 3.29B | -3.79% | 3,527,110 | 1.27B |
| 70 | ARQT | Arcutis Biotherapeutics, Inc. | 3.29B | 11.19% | 5,156,098 | 463.98M |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.23B | -3.32% | 2,156,013 | - |
| 72 | DNLI | Denali Therapeutics Inc. | 3.21B | -1.57% | 1,855,562 | 3.60M |
| 73 | RCUS | Arcus Biosciences, Inc. | 3.14B | 1.36% | 2,295,531 | 117.00M |
| 74 | CLDX | Celldex Therapeutics, Inc. | 3.04B | 0.52% | 1,001,436 | 158.00K |
| 75 | MBX | MBX Biosciences, Inc. | 2.97B | 0.80% | 1,159,806 | - |
| 76 | QURE | uniQure N.V. | 2.95B | -1.42% | 1,469,907 | 18.67M |
| 77 | ZLAB | Zai Lab Limited | 2.77B | -0.52% | 1,158,229 | 449.61M |
| 78 | IMNM | Immunome, Inc. | 2.66B | -2.05% | 1,317,836 | 4.02M |
| 79 | PGEN | Precigen, Inc. | 2.66B | 6.21% | 8,226,554 | 85.72M |
| 80 | PHVS | Pharvaris N.V. | 2.64B | -1.34% | 828,999 | - |
| 81 | IRON | Disc Medicine, Inc. | 2.63B | 1.89% | 433,917 | - |
| 82 | NRIX | Nurix Therapeutics, Inc. | 2.61B | 1.29% | 1,236,320 | 36.77M |
| 83 | VRDN | Viridian Therapeutics, Inc. | 2.54B | 2.79% | 1,671,880 | 71.13M |
| 84 | NAMS | NewAmsterdam Pharma Company N.V. | 2.53B | 0.09% | 1,238,419 | 7.12M |
| 85 | GPCR | Structure Therapeutics Inc. | 2.53B | -8.86% | 1,649,044 | - |
| 86 | HRMY | Harmony Biosciences Holdings, Inc. | 2.46B | 0.09% | 1,599,201 | 959.90M |
| 87 | MLYS | Mineralys Therapeutics, Inc. | 2.43B | -4.74% | 1,415,477 | - |
| 88 | SLS | SELLAS Life Sciences Group, Inc. | 2.35B | 3.28% | 5,126,237 | - |
| 89 | BEAM | Beam Therapeutics Inc. | 2.31B | -0.52% | 1,821,010 | 156.04M |
| 90 | NKTR | Nektar Therapeutics | 2.30B | 1.11% | 986,143 | 54.59M |
| 91 | VERA | Vera Therapeutics, Inc. | 2.29B | -5.64% | 3,911,879 | - |
| 92 | AUPH | Aurinia Pharmaceuticals Inc. | 2.26B | 5.15% | 1,171,463 | 311.51M |
| 93 | PVLA | Palvella Therapeutics, Inc. | 2.18B | 0.14% | 201,967 | - |
| 94 | OCUL | Ocular Therapeutix, Inc. | 2.17B | -3.14% | 3,405,702 | 52.06M |
| 95 | TRVI | Trevi Therapeutics, Inc. | 2.14B | -0.20% | 2,277,361 | - |
| 96 | URGN | UroGen Pharma Ltd. | 2.13B | 4.19% | 997,158 | 188.73M |
| 97 | ZBIO | Zenas BioPharma, Inc. | 2.11B | 1.22% | 746,406 | 1.00M |
| 98 | SRPT | Sarepta Therapeutics, Inc. | 2.09B | -4.63% | 2,509,690 | 1.97B |
| 99 | VCEL | Vericel Corporation | 2.06B | 1.23% | 490,480 | 306.30M |
| 100 | KOD | Kodiak Sciences Inc. | 2.06B | -0.67% | 707,938 | - |
| 101 | NUVB | Nuvation Bio Inc. | 2.03B | -0.34% | 2,781,413 | 169.90M |
| 102 | GENB | Generate Biomedicines, Inc. | 2.01B | -3.15% | 1,510,378 | 26.48M |
| 103 | ADMA | ADMA Biologics, Inc. | 1.99B | 3.37% | 2,766,567 | 512.28M |
| 104 | RAPP | Rapport Therapeutics, Inc. | 1.99B | -3.02% | 386,988 | 20.00M |
| 105 | AGIO | Agios Pharmaceuticals, Inc. | 1.97B | 0.43% | 863,546 | 98.34M |
| 106 | COAG | Hemab Therapeutics Holdings, Inc. | 1.91B | 2.14% | 597,198 | - |
| 107 | GHRS | GH Research PLC | 1.90B | 0.73% | 152,927 | - |
| 108 | FTRE | Fortrea Holdings Inc. | 1.90B | 1.22% | 2,689,866 | 2.68B |
| 109 | MESO | Mesoblast Limited | 1.89B | -2.24% | 243,834 | 120.25M |
| 110 | ZYME | Zymeworks Inc. | 1.86B | 0.73% | 686,981 | 37.13M |
| 111 | BHVN | Biohaven Ltd. | 1.82B | -2.59% | 2,253,127 | - |
| 112 | STOK | Stoke Therapeutics, Inc. | 1.80B | -0.85% | 589,325 | 27.59M |
| 113 | LKFT | Lakefront Biotherapeutics NV | 1.80B | -1.36% | 415,606 | 1.13B |
| 114 | SEPN | Septerna, Inc. | 1.79B | -1.08% | 304,943 | 98.88M |
| 115 | VIR | Vir Biotechnology, Inc. | 1.78B | 0.77% | 2,091,079 | 303.23M |
| 116 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.78B | -0.58% | 3,080,944 | 208.78M |
| 117 | XNCR | Xencor, Inc. | 1.76B | -0.17% | 1,230,452 | 104.97M |
| 118 | BRVE | Braveheart Bio, Inc. | 1.76B | 2.77% | 550,672 | - |
| 119 | NBTX | Nanobiotix S.A. | 1.76B | -2.44% | 198,703 | 38.27M |
| 120 | RXRX | Recursion Pharmaceuticals, Inc. | 1.71B | -1.54% | 14,774,567 | 54.86M |
| 121 | TYRA | Tyra Biosciences, Inc. | 1.67B | -4.25% | 1,138,615 | - |
| 122 | TSHA | Taysha Gene Therapies, Inc. | 1.65B | 0.20% | 4,346,866 | 5.49M |
| 123 | KLRA | Kailera Therapeutics, Inc. | 1.65B | -5.58% | 1,134,896 | - |
| 124 | IMCR | Immunocore Holdings plc | 1.63B | -0.52% | 460,266 | 430.78M |
| 125 | KARD | Kardigan, Inc. | 1.62B | -6.73% | 986,904 | - |
| 126 | NTLA | Intellia Therapeutics, Inc. | 1.61B | 1.14% | 4,590,884 | 59.51M |
| 127 | ANAB | AnaptysBio, Inc. | 1.61B | -0.68% | 394,069 | 232.39M |
| 128 | SNDX | Syndax Pharmaceuticals, Inc. | 1.54B | -4.48% | 2,332,304 | 252.25M |
| 129 | NVAX | Novavax, Inc. | 1.54B | 1.30% | 2,849,468 | 413.80M |
| 130 | AVLN | Avalyn Pharma Inc. | 1.54B | 1.25% | 244,455 | - |
| 131 | INVA | Innoviva, Inc. | 1.53B | 1.73% | 715,365 | 440.00M |
| 132 | LTGO | Latigo Biotherapeutics, Inc. | 1.53B | 0.22% | 438,880 | - |
| 133 | DMRA | Damora Therapeutics, Inc. | 1.51B | -0.89% | 1,241,830 | - |
| 134 | INBX | Inhibrx Biosciences, Inc. | 1.50B | -3.64% | 363,491 | 1.30M |
| 135 | BCAX | Bicara Therapeutics Inc. | 1.46B | -2.96% | 798,328 | - |
| 136 | AAPG | Ascentage Pharma Group International | 1.41B | -3.75% | 3,904 | 94.61M |
| 137 | TRAX | First Tracks Biotherapeutics, Inc. | 1.39B | 1.38% | 637,182 | - |
| 138 | DRTS | Alpha Tau Medical Ltd. | 1.39B | 1.14% | 671,585 | - |
| 139 | ABSI | Absci Corporation | 1.38B | 1.26% | 2,613,666 | 1.56M |
| 140 | LBRX | LB Pharmaceuticals Inc | 1.37B | -1.09% | 231,918 | - |
| 141 | AVBP | ArriVent BioPharma, Inc. | 1.36B | -1.14% | 379,428 | - |
| 142 | MAZE | Maze Therapeutics, Inc. | 1.33B | -1.30% | 385,657 | 20.00M |
| 143 | CGEM | Cullinan Therapeutics, Inc. | 1.33B | 0.44% | 825,671 | - |
| 144 | SVRA | Savara Inc. | 1.30B | -2.47% | 1,127,049 | - |
| 145 | ORIC | ORIC Pharmaceuticals, Inc. | 1.30B | 1.46% | 1,609,366 | - |
| 146 | VOR | Vor Biopharma Inc. | 1.30B | -1.66% | 1,496,852 | - |
| 147 | RARE | Ultragenyx Pharmaceutical Inc. | 1.27B | -1.45% | 5,031,174 | 717.00M |
| 148 | AKTS | Aktis Oncology, Inc. | 1.26B | 1.34% | 855,044 | 10.06M |
| 149 | OMER | Omeros Corporation | 1.26B | 0.99% | 2,108,068 | 38.42M |
| 150 | MGTX | MeiraGTx Holdings plc | 1.23B | - | 917,270 | 397.50M |
| 151 | REPL | Replimune Group, Inc. | 1.22B | -0.54% | 1,810,684 | - |
| 152 | SPTX | Seaport Therapeutics, Inc. | 1.19B | -3.57% | 235,897 | - |
| 153 | IMTX | Immatics N.V. | 1.18B | 0.47% | 711,873 | 47.65M |
| 154 | ANRO | Alto Neuroscience, Inc. | 1.18B | -0.83% | 548,380 | - |
| 155 | MNKD | MannKind Corporation | 1.14B | -0.28% | 2,228,278 | 393.63M |
| 156 | APMD | Apnimed, Inc. | 1.13B | 5.99% | 552,534 | 115.12M |
| 157 | ODTX | Odyssey Therapeutics, Inc. | 1.11B | 5.14% | 591,375 | 99.00K |
| 158 | GLUE | Monte Rosa Therapeutics, Inc. | 1.08B | -2.62% | 1,496,002 | 28.73M |
| 159 | MLTX | MoonLake Immunotherapeutics | 1.06B | 2.13% | 2,600,600 | - |
| 160 | OBX | Obsidian Therapeutics, Inc. | 1.06B | 0.88% | 1,167,023 | - |
| 161 | JBIO | Jade Biosciences, Inc. | 1.06B | -4.20% | 1,730,372 | - |
| 162 | SLBT | SL Science Holding Limited | 1.03B | -5.24% | 129,311 | 3.27M |
| 163 | CRVS | Corvus Pharmaceuticals, Inc. | 1.03B | -5.56% | 952,274 | - |
| 164 | ALMS | Alumis Inc. | 1.03B | -5.48% | 4,800,650 | 7.40M |
| 165 | ATTO | Attovia Therapeutics, Inc. | 1.02B | -6.12% | 293,372 | 1.80M |
| 166 | ANL | Adlai Nortye Group Ltd. | 999.46M | 3.47% | 220,825 | 18.06M |
| 167 | ABUS | Arbutus Biopharma Corporation | 999.13M | -0.20% | 4,009,332 | 181.72M |
| 168 | KURA | Kura Oncology, Inc. | 996.36M | -0.88% | 1,793,131 | 77.23M |
| 169 | JANX | Janux Therapeutics, Inc. | 993.17M | -1.19% | 1,161,629 | 24.00M |
| 170 | HELP | Cybin Inc. | 984.12M | 2.67% | 928,067 | - |
| 171 | SGP | SpyGlass Pharma, Inc. | 956.61M | -1.24% | 186,219 | - |
| 172 | SLDB | Solid Biosciences Inc. | 935.00M | 4.18% | 2,256,384 | - |
| 173 | IVA | Inventiva S.A. | 903.84M | -1.81% | 2,219,651 | 7.94M |
| 174 | LXRX | Lexicon Pharmaceuticals, Inc. | 898.81M | 0.50% | 2,151,486 | 41.47M |
| 175 | AVTX | Avalo Therapeutics, Inc. | 889.19M | 3.17% | 1,444,797 | 59.00K |
| 176 | WVE | Wave Life Sciences, Inc. | 887.70M | 1.01% | 2,990,804 | 65.37M |
| 177 | FTH | Faeth Therapeutics, Inc. | 884.78M | -3.19% | 572,187 | - |
| 178 | TBPH | Theravance Biopharma, Inc. | 884.18M | - | 461,688 | 104.31M |
| 179 | SANA | Sana Biotechnology, Inc. | 874.13M | -7.59% | 9,724,427 | - |
| 180 | IMMX | Immix Biopharma, Inc. | 852.75M | -1.81% | 1,421,938 | - |
| 181 | OLMA | Olema Pharmaceuticals, Inc. | 851.35M | -0.51% | 1,246,311 | - |
| 182 | ARDX | Ardelyx, Inc. | 844.75M | -0.29% | 5,376,737 | 450.89M |
| 183 | CADL | Candel Therapeutics, Inc. | 843.23M | -0.90% | 1,168,644 | - |
| 184 | RIGL | Rigel Pharmaceuticals, Inc. | 830.88M | 0.27% | 226,291 | 276.79M |
| 185 | GERN | Geron Corporation | 828.79M | -1.53% | 11,439,893 | 204.56M |
| 186 | CLYM | Climb Bio, Inc. | 810.43M | 1.44% | 2,622,123 | - |
| 187 | BLSM | BlossomHill Therapeutics, Inc. | 804.40M | 18.40% | 319,911 | - |
| 188 | ACRS | Aclaris Therapeutics, Inc. | 783.10M | -3.80% | 5,771,579 | 8.22M |
| 189 | DSGN | Design Therapeutics, Inc. | 782.58M | 2.25% | 985,133 | - |
| 190 | ACHV | Achieve Life Sciences, Inc. | 763.54M | 1.37% | 1,905,747 | - |
| 191 | FDMT | 4D Molecular Therapeutics, Inc. | 760.16M | 0.95% | 819,574 | 92.01M |
| 192 | SLN | Silence Therapeutics plc | 752.62M | 0.32% | 983,806 | 615.00K |
| 193 | PHAR | Pharming Group N.V. | 750.09M | 0.47% | 58,026 | 366.48M |
| 194 | ANNX | Annexon, Inc. | 745.05M | 0.26% | 4,515,067 | - |
| 195 | CBIO | Crescent Biopharma, Inc. | 735.32M | -8.62% | 528,883 | 11.88M |
| 196 | DBVT | DBV Technologies S.A. | 715.71M | 1.11% | 159,077 | 5.04M |
| 197 | NVCT | Nuvectis Pharma, Inc. | 712.56M | -0.23% | 136,415 | - |
| 198 | GYRE | Gyre Therapeutics, Inc. | 710.43M | 0.15% | 126,347 | 109.82M |
| 199 | ZVRA | Zevra Therapeutics, Inc. | 700.73M | 1.29% | 795,099 | 136.07M |
| 200 | AURA | Aura Biosciences, Inc. | 697.93M | -2.75% | 1,294,175 | - |
| 201 | NGNE | Neurogene Inc. | 693.79M | 2.91% | 232,129 | 925.00K |
| 202 | MDXG | MiMedx Group, Inc. | 689.45M | 0.21% | 1,094,840 | 355.17M |
| 203 | MNPR | Monopar Therapeutics Inc. | 680.95M | -2.76% | 89,865 | - |
| 204 | VSTM | Verastem, Inc. | 662.92M | -0.27% | 1,452,334 | 87.53M |
| 205 | SGMT | Sagimet Biosciences Inc. | 650.18M | - | 620,552 | - |
| 206 | MPLT | MapLight Therapeutics, Inc. | 633.56M | -5.63% | 613,865 | - |
| 207 | OABI | OmniAb, Inc. | 632.45M | - | 1,064,626 | 38.46M |
| 208 | ALT | Altimmune, Inc. | 630.24M | 0.31% | 3,331,818 | 31.00K |
| 209 | VALN | Valneva SE | 625.88M | 0.31% | 35,673 | 163.30M |
| 210 | OCS | Oculis Holding AG | 611.76M | -1.59% | 314,067 | 1.45M |
| 211 | PHAT | Phathom Pharmaceuticals, Inc. | 610.82M | -5.76% | 2,072,396 | 239.66M |
| 212 | CRMD | CorMedix Inc. | 609.52M | 0.77% | 664,712 | 462.25M |
| 213 | CTMX | CytomX Therapeutics, Inc. | 602.49M | 2.79% | 6,864,294 | 18.30M |
| 214 | STTK | Shattuck Labs, Inc. | 590.14M | -1.51% | 743,054 | 1.00M |
| 215 | ALLO | Allogene Therapeutics, Inc. | 583.88M | -1.74% | 5,648,084 | 4.64M |
| 216 | DRUG | Bright Minds Biosciences Inc. | 582.64M | -1.84% | 97,433 | - |
| 217 | AGMB | AgomAb Therapeutics NV | 561.92M | -6.17% | 120,332 | - |
| 218 | PROK | ProKidney Corp. | 559.30M | 6.32% | 1,813,747 | 818.00K |
| 219 | SCTX | Scribe Therapeutics Inc. | 550.91M | -8.09% | 325,969 | 33.30M |
| 220 | TECX | Tectonic Therapeutic, Inc. | 545.62M | -2.10% | 188,414 | - |
| 221 | PRME | Prime Medicine, Inc. | 533.71M | -4.46% | 3,285,407 | 4.07M |
| 222 | ARVN | Arvinas, Inc. | 533.55M | -1.21% | 742,605 | 316.70M |
| 223 | EPRX | Eupraxia Pharmaceuticals Inc. | 532.96M | -0.25% | 197,602 | - |
| 224 | RGNX | REGENXBIO Inc. | 526.79M | 0.38% | 1,231,598 | 174.48M |
| 225 | OVID | Ovid Therapeutics Inc. | 523.40M | -1.11% | 1,428,321 | 1.58M |
| 226 | ASMB | Assembly Biosciences, Inc. | 518.79M | -2.41% | 348,786 | 74.85M |
| 227 | CTNM | Contineum Therapeutics, Inc. | 517.67M | -0.83% | 785,874 | - |
| 228 | ENTX | Entera Bio Ltd. | 512.50M | 3.50% | 777,611 | 42.00K |
| 229 | AUTL | Autolus Therapeutics plc | 497.72M | -1.06% | 1,915,039 | 117.39M |
| 230 | CAPR | Capricor Therapeutics, Inc. | 497.67M | - | 2,386,177 | 11.13M |
| 231 | PBYI | Puma Biotechnology, Inc. | 484.71M | 1.51% | 188,826 | 231.24M |
| 232 | DNA | Ginkgo Bioworks Holdings, Inc. | 475.42M | 1.00% | 976,209 | 132.42M |
| 233 | VOGX | Vogenx, Inc. | 464.71M | 3.66% | 97,583 | - |
| 234 | EIKN | Eikon Therapeutics, Inc. | 460.94M | -10.33% | 989,382 | - |
| 235 | PRLD | Prelude Therapeutics Incorporated | 460.39M | -1.11% | 191,572 | 22.42M |
| 236 | RLMD | Relmada Therapeutics, Inc. | 450.15M | -4.95% | 824,322 | - |
| 237 | IRD | Opus Genetics, Inc. | 450.09M | -7.04% | 2,335,161 | 9.86M |
| 238 | ARCT | Arcturus Therapeutics Holdings Inc. | 443.40M | -1.52% | 851,435 | 29.37M |
| 239 | ZURA | Zura Bio Limited | 441.77M | -6.49% | 1,269,607 | - |
| 240 | INDP | Indaptus Therapeutics, Inc. | 427.71M | -11.81% | 1,200,627 | - |
| 241 | KYTX | Kyverna Therapeutics, Inc. | 426.72M | -0.86% | 685,739 | - |
| 242 | CCCC | C4 Therapeutics, Inc. | 424.44M | 0.58% | 2,320,844 | 35.04M |
| 243 | PRTA | Prothena Corporation plc | 423.02M | -1.08% | 398,330 | 54.53M |
| 244 | CABA | Cabaletta Bio, Inc. | 422.17M | -4.05% | 6,144,752 | - |
| 245 | IKT | Inhibikase Therapeutics, Inc. | 420.59M | - | 370,498 | 1.00 |
| 246 | ARTV | Artiva Biotherapeutics, Inc. | 420.46M | -3.48% | 516,917 | 251.00K |
| 247 | EDIT | Editas Medicine, Inc. | 416.20M | 3.04% | 2,493,469 | 47.01M |
| 248 | RZLT | Rezolute, Inc. | 415.78M | -4.10% | 2,047,197 | - |
| 249 | SPRY | ARS Pharmaceuticals, Inc. | 414.20M | -2.00% | 1,451,895 | 116.93M |
| 250 | AVIR | Atea Pharmaceuticals, Inc. | 413.05M | -1.53% | 274,171 | - |
| 251 | LRMR | Larimar Therapeutics, Inc. | 410.22M | 0.51% | 1,957,895 | - |
| 252 | TTRX | Turn Therapeutics Inc. | 408.69M | 1.93% | 150,338 | - |
| 253 | BNTC | Benitec Biopharma Inc. | 386.15M | 0.18% | 138,828 | - |
| 254 | RCKT | Rocket Pharmaceuticals, Inc. | 382.02M | 2.05% | 2,644,717 | - |
| 255 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 381.63M | -2.46% | 855,550 | - |
| 256 | VTVT | vTv Therapeutics Inc. | 378.46M | - | 91,474 | 36.84M |
| 257 | GALT | Galectin Therapeutics Inc. | 371.13M | -1.34% | 276,066 | - |
| 258 | FENC | Fennec Pharmaceuticals Inc. | 369.96M | -0.85% | 170,296 | 59.22M |
| 259 | ENTA | Enanta Pharmaceuticals, Inc. | 369.89M | 3.34% | 267,528 | 65.26M |
| 260 | OBIO | Orchestra BioMed Holdings, Inc. | 361.23M | -0.50% | 297,197 | 31.98M |
| 261 | DMAC | DiaMedica Therapeutics Inc. | 357.53M | 1.53% | 187,271 | - |
| 262 | XFOR | X4 Pharmaceuticals, Inc. | 348.01M | -3.04% | 973,333 | 15.85M |
| 263 | LXEO | Lexeo Therapeutics, Inc. | 341.30M | 0.73% | 619,510 | - |
| 264 | EVMN | Evommune, Inc. | 340.06M | -6.21% | 568,846 | 10.00M |
| 265 | OCGN | Ocugen, Inc. | 338.57M | 0.49% | 9,093,641 | 4.58M |
| 266 | IPSC | Century Therapeutics, Inc. | 336.80M | -6.06% | 825,447 | 109.16M |
| 267 | CMPX | Compass Therapeutics, Inc. | 329.56M | -1.08% | 2,242,945 | 850.00K |
| 268 | QTTB | Q32 Bio Inc. | 326.87M | -1.70% | 504,999 | 53.74M |
| 269 | AGEN | Agenus Inc. | 324.60M | 0.70% | 687,079 | 132.69M |
| 270 | SION | Sionna Therapeutics, Inc. | 318.30M | 2.33% | 1,970,789 | - |
| 271 | SABS | SAB Biotherapeutics, Inc. | 308.44M | -0.59% | 452,376 | 114.70K |
| 272 | ABEO | Abeona Therapeutics Inc. | 307.08M | -1.83% | 1,903,069 | 25.52M |
| 273 | VNDA | Vanda Pharmaceuticals Inc. | 302.31M | 0.20% | 441,249 | 215.72M |
| 274 | IFRX | InflaRx N.V. | 300.63M | 0.99% | 821,160 | -11.54K |
| 275 | EYPT | EyePoint, Inc. | 297.43M | -5.74% | 4,965,305 | 2.79M |
| 276 | PALI | Palisade Bio, Inc. | 294.52M | -16.13% | 8,407,625 | 500.00K |
| 277 | ZNTL | Zentalis Pharmaceuticals, Inc. | 293.48M | -0.96% | 1,225,804 | 26.87M |
| 278 | CUVL | Clinuvel Pharmaceuticals Limited | 292.42M | -1.53% | 13,593 | 65.05M |
| 279 | FATE | Fate Therapeutics, Inc. | 292.36M | 3.83% | 1,276,840 | 6.49M |
| 280 | VCRE | Vicore Pharma Holding AB (publ) | 291.94M | -0.47% | 14,462 | 412.09K |
| 281 | UPB | Upstream Bio, Inc. | 291.93M | -2.74% | 497,151 | 3.16M |
| 282 | FULC | Fulcrum Therapeutics, Inc. | 289.17M | 0.26% | 1,125,208 | 80.00M |
| 283 | IMRX | Immuneering Corporation | 287.90M | 0.23% | 900,508 | - |
| 284 | PYXS | Pyxis Oncology, Inc. | 278.58M | 0.30% | 640,040 | 11.04M |
| 285 | LCTX | Lineage Cell Therapeutics, Inc. | 270.61M | 0.94% | 1,639,485 | 13.08M |
| 286 | LYEL | Lyell Immunopharma, Inc. | 264.04M | -1.24% | 154,698 | 27.00K |
| 287 | ACIU | AC Immune SA | 263.48M | -1.12% | 124,399 | 21.67M |
| 288 | PRQR | ProQR Therapeutics N.V. | 262.49M | 1.09% | 741,853 | 21.05M |
| 289 | YDES | YD Bio Limited | 260.18M | -6.33% | 695,521 | 1.24M |
| 290 | MGNX | MacroGenics, Inc. | 259.90M | 0.99% | 315,644 | 175.14M |
| 291 | STRO | Sutro Biopharma, Inc. | 258.67M | -5.80% | 273,289 | 45.70M |
| 292 | BCYC | Bicycle Therapeutics plc | 254.77M | -0.82% | 599,854 | 61.21M |
| 293 | TRDA | Entrada Therapeutics, Inc. | 248.43M | 0.15% | 249,216 | 4.69M |
| 294 | CUE | Cue Biopharma, Inc. | 248.23M | 8.00% | 277,363 | 37.66M |
| 295 | FHTX | Foghorn Therapeutics Inc. | 247.64M | 1.21% | 354,919 | 36.74M |
| 296 | ALXO | ALX Oncology Holdings Inc. | 243.37M | -6.88% | 821,153 | - |
| 297 | CAMP | Camp4 Therapeutics Corporation | 242.23M | -7.88% | 300,786 | 4.22M |
| 298 | YARW | Yarrow Bioscience, Inc. | 241.91M | 1.96% | 74,189 | - |
| 299 | RNAC | Cartesian Therapeutics, Inc. | 239.32M | 0.25% | 117,994 | 1.48M |
| 300 | IVVD | Invivyd, Inc. | 237.37M | -2.98% | 3,593,976 | 58.37M |
| 301 | WHWK | Whitehawk Therapeutics, Inc. | 230.32M | -1.22% | 170,642 | 7.15M |
| 302 | GLSI | Greenwich LifeSciences, Inc. | 229.42M | -2.86% | 121,660 | - |
| 303 | NGEN | NervGen Pharma Corp. | 229.02M | -0.47% | 452,882 | - |
| 304 | CGEN | Compugen Ltd. | 228.29M | - | 117,640 | 74.00M |
| 305 | AVXL | Anavex Life Sciences Corp. | 218.76M | -3.28% | 906,011 | - |
| 306 | ELDN | Eledon Pharmaceuticals, Inc. | 217.18M | -1.48% | 738,768 | - |
| 307 | PLX | Protalix BioTherapeutics, Inc. | 215.93M | 0.75% | 1,059,225 | 80.62M |
| 308 | ALEC | Alector, Inc. | 214.94M | -5.41% | 622,260 | 13.86M |
| 309 | TARA | Protara Therapeutics, Inc. | 213.93M | -3.47% | 2,060,862 | - |
| 310 | VRXA | Veraxa Biotech AG | 213.53M | -0.66% | 47,547 | 29.54K |
| 311 | KROS | Keros Therapeutics, Inc. | 212.94M | -3.85% | 273,991 | 15.01M |
| 312 | ADAG | Adagene Inc. | 212.84M | 6.73% | 319,202 | 9.29M |
| 313 | SLGL | Sol-Gel Technologies Ltd. | 207.70M | -1.49% | 54,391 | 1.80M |
| 314 | NKTX | Nkarta, Inc. | 205.56M | -0.35% | 642,022 | - |
| 315 | KRRO | Korro Bio, Inc. | 203.66M | -1.71% | 304,648 | 2.38M |
| 316 | TNXP | Tonix Pharmaceuticals Holding Corp. | 201.70M | 1.20% | 273,634 | 29.10M |
| 317 | ANTX | AN2 Therapeutics, Inc. | 201.51M | -0.37% | 146,044 | - |
| 318 | PEPG | PepGen Inc. | 200.85M | 0.35% | 613,475 | - |
| 319 | SRZN | Surrozen, Inc. | 198.99M | -4.73% | 116,735 | 11.51M |
| 320 | MSLE | Satellos Bioscience Inc. | 198.33M | -0.64% | 29,773 | - |
| 321 | ORMP | Oramed Pharmaceuticals Inc. | 192.18M | - | 122,764 | 2.00M |
| 322 | ABOS | Acumen Pharmaceuticals, Inc. | 188.75M | -9.69% | 369,175 | - |
| 323 | CHRS | Coherus Oncology, Inc. | 188.49M | -8.27% | 1,290,589 | 50.94M |
| 324 | VYGR | Voyager Therapeutics, Inc. | 187.93M | -1.29% | 632,654 | 34.46M |
| 325 | DTIL | Precision BioSciences, Inc. | 183.00M | 0.30% | 289,207 | 45.06M |
| 326 | ACOG | Alpha Cognition Inc. | 182.93M | -4.55% | 242,395 | 15.26M |
| 327 | NBP | NovaBridge Biosciences | 182.12M | -1.26% | 328,874 | - |
| 328 | MDWD | MediWound Ltd. | 170.67M | -1.86% | 79,022 | 11.86M |
| 329 | IPHA | Innate Pharma S.A. | 169.07M | 8.06% | 210,923 | 10.57M |
| 330 | NERV | Minerva Neurosciences, Inc. | 166.40M | -9.01% | 224,504 | - |
| 331 | OTLK | Outlook Therapeutics, Inc. | 164.79M | 0.58% | 7,315,343 | -1.16M |
| 332 | CNTN | Canton Strategic Holdings, Inc. | 162.55M | -0.24% | 1,197,058 | 1.50M |
| 333 | RNA | Atrium Therapeutics, Inc. | 162.50M | -5.85% | 356,359 | 35.84M |
| 334 | HUMA | Humacyte, Inc. | 158.34M | 3.34% | 4,958,502 | 2.12M |
| 335 | SPRB | Spruce Biosciences, Inc. | 155.66M | -1.83% | 100,403 | 697.00K |
| 336 | MENS | Jyong Biotech Ltd. | 152.92M | -2.83% | 27,547 | - |
| 337 | ARMP | Armata Pharmaceuticals, Inc. | 151.33M | -7.50% | 307,471 | 5.54M |
| 338 | MOLN | Molecular Partners AG | 150.12M | -6.67% | 2,099 | 856.30K |
| 339 | TNYA | Tenaya Therapeutics, Inc. | 147.48M | -1.91% | 1,942,519 | 1.34M |
| 340 | CDXS | Codexis, Inc. | 146.74M | -4.29% | 954,123 | 77.68M |
| 341 | NMRA | Neumora Therapeutics, Inc. | 145.28M | -6.99% | 3,215,464 | - |
| 342 | NRXP | NRx Pharmaceuticals, Inc. | 144.93M | -1.47% | 715,940 | 3.39M |
| 343 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 140.42M | 4.91% | 1,229,328 | - |
| 344 | KZIA | Kazia Therapeutics Limited | 139.78M | -1.54% | 353,819 | 1.27M |
| 345 | IMUX | Immunic, Inc. | 138.08M | -2.41% | 229,149 | - |
| 346 | CRBU | Caribou Biosciences, Inc. | 134.01M | -1.57% | 969,349 | 10.04M |
| 347 | UNCY | Unicycive Therapeutics, Inc. | 133.15M | 1.49% | 906,352 | - |
| 348 | LENZ | LENZ Therapeutics, Inc. | 130.08M | -2.13% | 762,495 | 21.48M |
| 349 | HURA | TuHURA Biosciences, Inc. | 129.37M | - | 108,053 | - |
| 350 | ENGN | enGene Therapeutics Inc. | 128.00M | 1.06% | 579,235 | - |
| 351 | BMEA | Biomea Fusion, Inc. | 126.12M | -3.33% | 1,596,476 | - |
| 352 | MIST | Milestone Pharmaceuticals Inc. | 125.30M | -4.15% | 1,568,720 | 2.34M |
| 353 | MNOV | MediciNova, Inc. | 124.04M | 24.75% | 1,420,846 | 920.48K |
| 354 | NAUT | Nautilus Biotechnology, Inc. | 123.70M | 9.09% | 1,149,118 | 190.00K |
| 355 | CNXU | Conexeu Sciences Inc. | 123.62M | 3.82% | 114,654 | - |
| 356 | INO | Inovio Pharmaceuticals, Inc. | 118.91M | -0.86% | 3,379,923 | 65.34K |
| 357 | EQ | Equillium, Inc. | 117.62M | -9.51% | 770,193 | 4.39M |
| 358 | OKUR | OnKure Therapeutics, Inc. | 116.63M | -1.71% | 83,866 | - |
| 359 | PMN | ProMIS Neurosciences, Inc. | 115.50M | -0.08% | 33,168 | - |
| 360 | CBUS | Cibus, Inc. | 115.41M | -4.43% | 115,025 | 4.35M |
| 361 | AARD | Aardvark Therapeutics, Inc. | 113.36M | 3.19% | 47,908 | - |
| 362 | BDTX | Black Diamond Therapeutics, Inc. | 111.46M | -1.52% | 733,891 | 70.00M |
| 363 | VANI | Vivani Medical, Inc. | 110.05M | -0.81% | 142,261 | - |
| 364 | PMVP | PMV Pharmaceuticals, Inc. | 107.98M | 5.15% | 1,021,948 | - |
| 365 | PYPD | PolyPid Ltd. | 105.82M | 0.97% | 76,489 | - |
| 366 | RANI | Rani Therapeutics Holdings, Inc. | 105.38M | -7.97% | 1,440,807 | 4.88M |
| 367 | SEER | Seer, Inc. | 105.21M | - | 147,243 | 14.22M |
| 368 | COYA | Coya Therapeutics, Inc. | 105.09M | -3.66% | 129,321 | 8.02M |
| 369 | CRDF | Cardiff Oncology, Inc. | 105.02M | 0.75% | 1,854,527 | 508.00K |
| 370 | GNLX | Genelux Corporation | 104.86M | -5.26% | 661,718 | 8.00K |
| 371 | TENX | Tenax Therapeutics, Inc. | 104.25M | -0.55% | 2,285,907 | - |
| 372 | ATRA | Atara Biotherapeutics, Inc. | 101.48M | 7.10% | 116,739 | 6.19M |
| 373 | PLYX | Polaryx Therapeutics, Inc. | 101.19M | -0.73% | 28,029 | - |
| 374 | TLSA | Tiziana Life Sciences Ltd | 99.58M | -9.61% | 852,657 | - |
| 375 | ONCY | Oncolytics Biotech Inc. | 98.03M | -1.44% | 958,757 | - |
| 376 | ACET | Adicet Bio, Inc. | 97.42M | 6.35% | 257,705 | - |
| 377 | CGTX | Cognition Therapeutics, Inc. | 97.00M | -1.45% | 531,679 | - |
| 378 | CLLS | Cellectis S.A. | 96.56M | -14.60% | 672,270 | 63.82M |
| 379 | RLYB | Rallybio Corporation | 90.76M | -0.75% | 18,528 | 646.00K |
| 380 | ANIX | Anixa Biosciences, Inc. | 90.39M | -3.35% | 557,423 | - |
| 381 | GUTS | Fractyl Health, Inc. | 89.54M | -0.44% | 860,729 | 3.00K |
| 382 | ICCC | ImmuCell Corporation | 87.28M | 0.31% | 32,134 | 30.68M |
| 383 | NRXS | NeurAxis, Inc. | 87.15M | 21.75% | 1,075,213 | 5.32M |
| 384 | NTRB | Nutriband Inc. | 85.45M | 3.08% | 44,731 | 1.62M |
| 385 | MAIA | MAIA Biotechnology, Inc. | 85.16M | 4.48% | 907,382 | - |
| 386 | ALDX | Aldeyra Therapeutics, Inc. | 82.65M | - | 791,852 | - |
| 387 | FBIO | Fortress Biotech, Inc. | 82.04M | -1.20% | 352,883 | 68.47M |
| 388 | OSTX | OS Therapies Incorporated | 80.72M | -1.69% | 421,327 | - |
| 389 | CNTB | Connect Biopharma Holdings Limited | 78.09M | 5.98% | 3,427,204 | 2.95M |
| 390 | VRCA | Verrica Pharmaceuticals Inc. | 77.82M | -1.09% | 48,264 | 30.32M |
| 391 | TELO | Telomir Pharmaceuticals, Inc. | 77.72M | -3.42% | 37,933 | - |
| 392 | IBIO | iBio, Inc. | 75.88M | -0.84% | 407,017 | 100.00K |
| 393 | KLRS | Kalaris Therapeutics, Inc. | 75.70M | -0.63% | 61,745 | - |
| 394 | GANX | Gain Therapeutics, Inc. | 75.07M | 0.58% | 265,723 | - |
| 395 | PTHS | Pelthos Therapeutics Inc. | 74.35M | -4.43% | 63,521 | 43.30M |
| 396 | NTHI | NeOnc Technologies Holdings, Inc. | 74.32M | -9.67% | 320,552 | 39.99K |
| 397 | CING | Cingulate Inc. | 74.02M | -0.39% | 76,731 | - |
| 398 | BSEM | BioStem Technologies, Inc. | 73.72M | 2.99% | 76,374 | 34.59M |
| 399 | ACRV | Acrivon Therapeutics, Inc. | 72.85M | -7.10% | 764,970 | - |
| 400 | ELOX | Eloxx Pharmaceuticals, Inc. | 71.16M | -3.40% | 18,000 | - |
| 401 | RNXT | RenovoRx, Inc. | 69.95M | -9.88% | 1,035,813 | 1.98M |
| 402 | OKYO | OKYO Pharma Limited | 69.80M | -0.75% | 85,984 | - |
| 403 | CSBR | Champions Oncology, Inc. | 69.41M | 4.74% | 31,705 | 60.66M |
| 404 | ATHE | Alterity Therapeutics Limited | 67.69M | 10.00% | 10,385 | 2.50M |
| 405 | GOSS | Gossamer Bio, Inc. | 66.97M | 5.59% | 272,118 | 53.29M |
| 406 | ALPS | Alps Group Inc | 66.56M | - | 113,835 | 3.74M |
| 407 | PLRX | Pliant Therapeutics, Inc. | 66.26M | -4.46% | 982,061 | - |
| 408 | XBIT | XBiotech Inc. | 66.16M | -1.14% | 49,066 | - |
| 409 | SPRO | Spero Therapeutics, Inc. | 64.64M | -1.77% | 439,640 | 47.00M |
| 410 | BOLD | Boundless Bio, Inc. | 64.15M | 0.36% | 102,234 | - |
| 411 | LONA | LeonaBio, Inc. | 63.97M | -6.22% | 51,344 | - |
| 412 | RNTX | Rein Therapeutics Inc. | 60.57M | -0.76% | 266,509 | - |
| 413 | HRTX | Heron Therapeutics, Inc. | 60.34M | 1.21% | 1,106,476 | 151.18M |
| 414 | XLO | Xilio Therapeutics, Inc. | 59.22M | -0.33% | 11,532 | 64.09M |
| 415 | INKT | MiNK Therapeutics, Inc. | 59.14M | 1.58% | 4,699 | - |
| 416 | DWTX | Dogwood Therapeutics, Inc. | 57.79M | -1.73% | 84,274 | - |
| 417 | EXOZ | eXoZymes, Inc. | 57.17M | -6.38% | 12,283 | -700.00 |
| 418 | INMB | INmune Bio Inc. | 56.90M | -9.29% | 923,287 | 50.00K |
| 419 | IMA | ImageneBio, Inc. | 55.96M | 0.20% | 20,352 | 800.00K |
| 420 | PDSB | PDS Biotechnology Corporation | 55.45M | 69.25% | 196,515,904 | - |
| 421 | SER | Serina Therapeutics, Inc. | 54.87M | -8.09% | 21,478 | 130.00K |
| 422 | IBO | Impact BioMedical Inc. | 53.69M | -5.86% | 164,691 | 35.00K |
| 423 | HYFT | MindWalk Holdings Corp. | 53.10M | -2.16% | 391,819 | 11.57M |
| 424 | EDSA | Edesa Biotech, Inc. | 52.29M | -6.07% | 94,355 | - |
| 425 | HYPD | Hyperion DeFi, Inc. | 50.81M | -0.61% | 244,095 | 1.40M |
| 426 | CLNN | Clene Inc. | 49.60M | -3.98% | 256,176 | 197.00K |
| 427 | TVGN | Tevogen Inc. | 49.55M | -1.81% | 2,637 | - |
| 428 | IMMP | Immutep Limited | 49.40M | -1.00% | 256,672 | 13.79M |
| 429 | TIL | Instil Bio, Inc. | 48.69M | 0.55% | 8,532 | - |
| 430 | APLM | Apollomics, Inc. | 48.54M | -7.97% | 10,339 | 8.84M |
| 431 | ELTX | Elicio Therapeutics, Inc. | 46.52M | -11.06% | 629,866 | - |
| 432 | GRCE | Grace Therapeutics, Inc. | 45.02M | -4.04% | 65,825 | - |
| 433 | HOWL | Werewolf Therapeutics, Inc. | 44.66M | -6.22% | 1,513,231 | 21.00M |
| 434 | ANVS | Annovis Bio, Inc. | 44.31M | -7.14% | 1,432,807 | - |
| 435 | MGX | Metagenomi Therapeutics, Inc. | 43.63M | -0.43% | 105,656 | 13.56M |
| 436 | MREO | Mereo BioPharma Group plc | 42.48M | -6.67% | 1,520,795 | 500.00K |
| 437 | MCRB | Seres Therapeutics, Inc. | 41.85M | -8.48% | 83,718 | 1.88M |
| 438 | VERU | Veru Inc. | 39.56M | -0.85% | 130,207 | 16.89M |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 38.99M | -0.80% | 59,768 | 35.09M |
| 440 | KPTI | Karyopharm Therapeutics Inc. | 38.56M | 10.39% | 1,353,796 | 146.62M |
| 441 | ATYR | aTyr Pharma, Inc. | 37.68M | -1.31% | 954,173 | 190.00K |
| 442 | CELU | Celularity Inc. | 37.34M | 4.03% | 180,842 | 26.55M |
| 443 | CRVO | CervoMed Inc. | 36.89M | -0.41% | 100,320 | 331.30K |
| 444 | CNTX | Context Therapeutics Inc. | 34.82M | 4.01% | 2,129,051 | - |
| 445 | LITS | Lite Strategy, Inc. | 34.71M | -6.42% | 318,757 | - |
| 446 | FLNA | Filana Therapeutics, Inc. | 33.05M | -1.77% | 379,804 | - |
| 447 | ALGS | Aligos Therapeutics, Inc. | 31.54M | 1.20% | 41,650 | 31.52M |
| 448 | BCTX | BriaCell Therapeutics Corp. | 31.09M | -0.56% | 66,370 | - |
| 449 | KYNB | Kyntra Bio, Inc. | 30.81M | -2.06% | 17,728 | 4.62M |
| 450 | QNTM | Quantum BioPharma Ltd. | 29.52M | 5.49% | 200,088 | - |
| 451 | BYSI | BeyondSpring Inc. | 29.15M | -5.56% | 35,655 | 1.88M |
| 452 | RNAZ | TransCode Therapeutics, Inc. | 28.44M | 5.00% | 18,697 | - |
| 453 | IGC | IGC Pharma, Inc. | 28.12M | 1.91% | 473,630 | 1.11M |
| 454 | ABVC | ABVC BioPharma, Inc. | 28.00M | 0.93% | 192,825 | 797.92K |
| 455 | ESLA | Estrella Immunopharma, Inc. | 27.83M | 4.73% | 45,210 | - |
| 456 | QNCX | Quince Therapeutics, Inc. | 27.63M | -5.82% | 49,146 | - |
| 457 | NXTC | NextCure, Inc. | 27.60M | -5.34% | 106,978 | - |
| 458 | NNVC | NanoViricides, Inc. | 27.34M | 14.29% | 1,308,971 | - |
| 459 | CVM | CEL-SCI Corporation | 26.03M | - | 72,610 | - |
| 460 | EVAX | Evaxion A/S | 25.44M | 0.33% | 73,871 | 7.49M |
| 461 | RADX | Radiopharm Theranostics Limited | 24.75M | 9.87% | 187,795 | 9.34M |
| 462 | LTRN | Lantern Pharma Inc. | 24.67M | 13.53% | 362,445 | - |
| 463 | ATOS | Atossa Therapeutics, Inc. | 24.15M | 2.11% | 45,760 | - |
| 464 | ACTU | Actuate Therapeutics, Inc. | 23.95M | 1.39% | 208,794 | - |
| 465 | TVRD | Tvardi Therapeutics, Inc. | 23.08M | -1.70% | 126,466 | - |
| 466 | TCRX | TScan Therapeutics, Inc. | 22.43M | 3.02% | 884,108 | 7.11M |
| 467 | PLRZ | Polyrizon Ltd. | 22.41M | -6.50% | 11,979 | - |
| 468 | CLRB | Cellectar Biosciences, Inc. | 22.31M | 1.72% | 73,031 | - |
| 469 | PBM | Psyence Biomedical Ltd. | 22.20M | -4.12% | 40,220 | - |
| 470 | COCP | Cocrystal Pharma, Inc. | 21.96M | - | 46,842 | 330.00K |
| 471 | LGVN | Longeveron Inc. | 21.30M | -2.62% | 316,645 | 1.19M |
| 472 | GRDX | GridAI Technologies Corp. | 20.82M | -0.66% | 38,995 | - |
| 473 | NEUP | Neuphoria Therapeutics Inc. | 20.27M | -0.79% | 36,787 | -13.27K |
| 474 | AKTX | Akari Therapeutics, Plc | 19.70M | -1.27% | 16,369 | - |
| 475 | NCEL | NewcelX Ltd. | 19.58M | 2.11% | 4,645 | - |
| 476 | TPST | Tempest Therapeutics, Inc. | 19.34M | 60.18% | 104,592,053 | - |
| 477 | JSPR | Jasper Therapeutics, Inc. | 19.33M | 1.89% | 505,281 | - |
| 478 | CMMB | Chemomab Therapeutics Ltd. | 19.20M | 7.29% | 115,058 | - |
| 479 | MRKR | Marker Therapeutics, Inc. | 19.01M | -2.56% | 35,858 | 3.55M |
| 480 | BCDA | BioCardia, Inc. | 18.92M | 1.63% | 1,529,300 | 3.00K |
| 481 | ALLR | Allarity Therapeutics, Inc. | 18.38M | 4.05% | 55,495 | 345.00K |
| 482 | PTN | Palatin Technologies, Inc. | 18.10M | -13.53% | 137,448 | 12.88M |
| 483 | LPCN | Lipocine Inc. | 17.81M | -1.14% | 63,961 | 1.57M |
| 484 | KTTA | Pasithea Therapeutics Corp. | 16.37M | -2.00% | 80,717 | - |
| 485 | PASG | Passage Bio, Inc. | 15.64M | -0.21% | 18,038 | - |
| 486 | CNSY | Cerenome, Inc. | 15.48M | -3.77% | 65,746 | 4.20M |
| 487 | CTXR | Citius Pharmaceuticals, Inc. | 15.37M | -0.02% | 139,284 | 7.11M |
| 488 | DYAI | Dyadic International, Inc. | 14.67M | -5.89% | 558,851 | 3.80M |
| 489 | MBRX | Moleculin Biotech, Inc. | 14.41M | -1.54% | 273,774 | - |
| 490 | ENLV | Enlivex Ltd. | 14.18M | -8.11% | 410,624 | - |
| 491 | GTBP | GT Biopharma, Inc. | 14.09M | -13.22% | 107,903 | - |
| 492 | PLUR | Pluri Inc. | 14.07M | -2.90% | 30,753 | 1.02M |
| 493 | NIKI | Niki BioSolutions, Inc. | 14.02M | -5.92% | 18,148 | - |
| 494 | QNRX | Quoin Pharmaceuticals, Ltd. | 13.86M | 1.47% | 52,123 | - |
| 495 | ADIL | Adial Pharmaceuticals, Inc. | 13.76M | 4.80% | 29,671 | - |
| 496 | HIND | Vyome Holdings, Inc. | 13.69M | -2.99% | 5,452 | 129.73K |
| 497 | ICU | SeaStar Medical Holding Corporation | 13.57M | 1.99% | 15,741 | 1.71M |
| 498 | CALC | CalciMedica, Inc. | 13.52M | - | 68,537 | - |
| 499 | LSTA | Lisata Therapeutics, Inc. | 13.25M | -4.55% | 93,541 | 100.00K |
| 500 | BIVI | BioVie Inc. | 12.97M | -1.71% | 439,959 | - |